This inventor holds 3 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Gilead Sciences, Inc., Istitute Di Ricerche Di Biologia Molecolare P. Angeletti S.p.a., Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa. Active years: 2010-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Doylestown, PA (US) (2010)
- Belmont, CA (US) (2010 - 2021)
Company Filing History:
1 out of 946 
1 out of 2 
1 out of 47 
Years Active: 2010-2021
Title: Romas Geleziunas: Innovator in HIV Treatment
Introduction
Romas Geleziunas is a notable inventor based in Belmont, California, recognized for his contributions to the field of HIV treatment. With a total of three patents to his name, he has made significant strides in developing innovative therapeutic methods.
Latest Patents
Geleziunas's latest patents include groundbreaking work on modulators of toll-like receptors for the treatment of HIV. This patent provides methods, uses, pharmaceutical regimens, compositions, and kits that comprise modulators of TLR7, which are useful in treating HIV infections. Another significant patent involves covalently stabilized chimeric coiled-coil HIV gp41 N-peptides with improved antiviral activity. This invention discloses methods for covalently stabilizing alpha-helical, chimeric peptides within a coiled-coil structure, which mimic the internal coiled-coil motif of the HIV gp41 ectodomain. These peptides represent a potent approach to inhibit HIV infectivity by targeting the virus-host cell membrane fusion process.
Career Highlights
Throughout his career, Romas Geleziunas has worked with prominent organizations, including Merck Sharp & Dohme Corporation and Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa. His work in these institutions has contributed to the advancement of pharmaceutical research and development.
Collaborations
Geleziunas has collaborated with esteemed colleagues such as Elisabetta Bianchi and Antonello Pessi, further enhancing the impact of his research in the field of HIV treatment.
Conclusion
Romas Geleziunas stands out as an influential inventor in the realm of HIV research, with his innovative patents paving the way for potential therapeutic advancements. His dedication to improving treatment options for HIV patients is commendable and highlights the importance of continued research in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile